AI-generated summary
The authors report a living systematic review and network meta-analysis of 104 randomized trials in 17,509 children comparing myopia control interventions. Repeated low intensity red light, high-dose atropine and medium-dose atropine were associated with slower myopia progression versus controls at one year, with the authors noting that results were often heterogeneous and evidence beyond two years was limited.
- Participants
- 17,509
- Studies included
- 104
- Who or what was studied
- Children aged 4 to 18 years with myopia or at risk of myopia progression, enrolled in randomized controlled trials
- Limits stated in the abstract
- Most networks were poorly connected so estimates rely mainly on direct comparisons, certainty of evidence was often low or very low, and evidence for two years and beyond and on adverse events was limited.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Myopia, Systematic review, Meta-analysis, Dose, Repeated low-level red light, Risk of bias, Digital object identifier, Confidence interval. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.